Gossamer Bio Inc. (GOSS) Reports Q4 Loss of $0.88/sh

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.88), versus ($0.89) reported last year.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
• Navios Maritime Partners (NMM) Tops Q2 EPS by 34c